Individualised Modelling for Preoperative Planning of Total Knee Replacement Surgery

Total knee replacement (TKR) surgery is routinely prescribed for patients with severe knee osteoarthritis to alleviate the pain and restore the kinematics. Although this procedure was proven to be successful in reducing the joint pain, the number of failures and the low patients’ satisfaction suggest that while the number of reoperations is small, the surgery frequently fail to restore the function in full. The main cause are surgical techniques which inadequately address the problem of balancing the knee soft tissues. The preoperative planning technique allows to manufacture subject-specific cutting guides that improves the placement of the prosthesis, however the knee soft tissue is ignored. The objective of this dissertation was to create an optimized preplanning procedure to compute the soft tissue balance along with the placement of the prosthesis to ensure mechanical stability. The dissertation comprises the development of CT based static and quasi-static knee models able to estimate the postoperative length of the collateral lateral ligaments using a dataset of seven TKR patients; In addition, a subject-specific dynamic musculoskeletal model of the lower limb was created using in vivo knee contact forces to perform the same analysis during walking. The models were evaluated by their ability to predict the postoperative elongation using a threshold based on the 10 % of the preoperative length, through which the model detected whether an elongation was acceptable. The results showed that the subject-specific static model is the best solution to be included in the optimized, subject-specific, preoperative planning framework; full order musculoskeletal model allowed to estimate the postoperative length of the ligaments during walking, and at least in principle while performing any other activity. Unlike the current methodology used in clinic this optimized preoperative planning framework might help the surgeon to understand how the position of the TKR affects the knee soft tissue

Il problema del divino nel pensiero di Emmanuel Levinas

Dopo una presentazione globale del pensiero dell'autore, l'elaborato tenta di ricostruire le modalità con cui viene affrontato il problema «Dio», ripercorrendo sia le opere filosofiche sia quelle a stampo confessionale, per scoprire che due mondi in apparenza distanti (quello «greco» della filosofia e quello del pensiero ebraico ed in particolare del Talmud) sono entrambi necessari e si influenzano in modo reciproco

Visceral Leishmaniasis Associated with B-Cell Chronic Lymphocytic Leukemia: Report of a Case and Review of the Literature

Infections often complicate the course of hematological diseases and may represent a diagnostic challenge. In particular, visceral leishmaniasis diagnosis may be missed in lymphoma patients, as lymphoma-related immunosuppression can lead to a misleadingly negative Leishmania serology and to atypical clinical manifestations, including the lack of fever, considered a common symptom in leishmaniasis. Herein, we report a case of visceral leishmaniasis in a patient with a long history of B-cell chronic lymphocytic leukemia presenting with increasing fatigue and diarrhea, in the absence of fever. Leishmania serology was negative. Bone marrow biopsy performed with the clinical suspicion of transformation to high-grade lymphoma disclosed intracytoplasmic inclusion bodies resembling Leishmania amastigotes within the cytoplasm of macrophages, and CD1a immunohistochemical expression helped to confirm the diagnosis of leishmaniasis. Liposomal amphotericin B was administered with complete symptom resolution. The correct identification of Leishmania is critical as visceral leishmaniasis represents a severe disease with an often fatal outcome, particularly in frail patients, unless promptly recognized and adequately treated. A review of the literature of visceral leishmaniasis cases occurring in B-cell chronic lymphocytic leukemia patients is performed

Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: A tissue micro array-based multicenter study

Objectives: Tumor angiogenesis is an essential and complex process necessary for the growth of all tumors which represents a potential therapeutic target. Angiogenesis inhibitors targeting vascular endothelial growth factor (VEGF) or their receptor tyrosine kinases have been approved by the FDA. In thymic epithelial tumors (TET), targeted therapies have been sporadically applied due to their rarity. To ascertain the presence of potential therapeutic targets, we analyzed by immunohistochemistry the expression of angiogenesis-related biomarkers in a large series of TET arranged in Tissue Micro Arrays (TMA). Materials and methods: We assessed by immunohistochemistry the expression of the possible molecular target of anti-angiogenic therapy, i.e. VEGFA, VEGFC, VEGFD, VEGFR1, VEGFR2, VEGFR3, and PDGFRβ, in a TMA series of 200 TET collected in the framework of a multi-institutional collaborative project for Rare Diseases. Results: When compared to the low-risk tumors, high-risk TET (B2, B3, carcinomas) contained higher proportion of cancer cells expressing VEGFA, VEGFC and VEGFD (P< 0.001, P< 0.001, and P< 0.001) growth factors, and their receptors VEGFR1 (P= 0.002), VEGFR2 (P= 0.013), and VEGFR3 (P= 0.041). No differences were observed in terms of PDGFRβ expression. Conclusions: According to our data, it is possible to hypothesize the existence of multiple paracrine and/or autocrine loops in TET, particularly in the high-risk ones, involved in TET growth and progression. Anti-angiogenic agents, directed to inhibit these loops, are therefore to be considered as potential tools in advanced TET therapy. © 2014 Elsevier Ireland Ltd.Abstract OBJECTIVES: Tumor angiogenesis is an essential and complex process necessary for the growth of all tumors which represents a potential therapeutic target. Angiogenesis inhibitors targeting vascular endothelial growth factor (VEGF) or their receptor tyrosine kinases have been approved by the FDA. In thymic epithelial tumors (TET), targeted therapies have been sporadically applied due to their rarity. To ascertain the presence of potential therapeutic targets, we analyzed by immunohistochemistry the expression of angiogenesis-related biomarkers in a large series of TET arranged in Tissue Micro Arrays (TMA). MATERIALS AND METHODS: We assessed by immunohistochemistry the expression of the possible molecular target of anti-angiogenic therapy, i.e. VEGFA, VEGFC, VEGFD, VEGFR1, VEGFR2, VEGFR3, and PDGFRβ, in a TMA series of 200 TET collected in the framework of a multi-institutional collaborative project for Rare Diseases. RESULTS: When compared to the low-risk tumors, high-risk